Home LiteratureArticle Details
PMID: 10353737 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.

Brown LF, Guidi AJ, Schnitt SJ, Van De Water L, Iruela-Arispe ML, Yeo TK, Tognazzi K, Dvorak HF

Abstract

The generation of vascular stroma is essential for solid tumor growth and involves stimulatory and inhibiting factors as well as stromal components that regulate functions such as cellular adhesion, migration, and gene expression. In an effort to obtain a more integrated understanding of vascular stroma formation in breast carcinoma, we examined expression of the angiogenic factor vascular permeability factor (VPF)/vascular endothelial growth factor (VEGF); the VPF/VEGF receptors flt-1 and KDR; thrombospondin-1, which has been reported to inhibit angiogenesis; and the stromal components collagen type I, total fibronectin, ED-A+ fibronectin, versican, and decorin by mRNA in situ hybridization on frozen sections of 113 blocks of breast tissue from 68 patients including 28 sections of breast tissue without malignancy, 18 with in situ carcinomas, 56 with invasive carcinomas, and 8 with metastatic carcinomas. A characteristic expression profile emerged that was remarkably similar in invasive carcinoma, carcinoma in situ, and metastatic carcinoma, with the following characteristics: strong tumor cell expression of VPF/VEGF; strong endothelial cell expression of VPF/VEGF receptors; strong expression of thrombospondin-1 by stromal cells and occasionally by tumor cells; and strong stromal cell expression of collagen type I, total fibronectin, ED-A+ fibronectin, versican, and decorin. The formation of vascular stroma preceded invasion, raising the possibility that tumor cells invade not into normal breast stroma but rather into a richly vascular stroma that they have induced. Similarly, tumor cells at sites of metastasis appear to induce the vascular stroma in which they grow. We conclude that a distinct pattern of mRNA expression characterizes the generation of vascular stroma in breast cancer and that the formation of vascular stroma may play a role not only in growth of the primary tumor but also in invasion and metastasis.

MeSH Terms
Adenocarcinoma, Mucinous/blood supply,chemistry,pathology Biomarkers Biopsy Breast/blood supply,chemistry Breast Neoplasms/blood supply,chemistry,pathology Carcinoma/blood supply,chemistry,pathology Carcinoma in Situ/blood supply,chemistry Carcinoma, Ductal, Breast/blood supply,chemistry,pathology Carcinoma, Intraductal, Noninfiltrating/blood supply,chemistry,pathology Carcinoma, Lobular/blood supply,chemistry,pathology Chondroitin Sulfate Proteoglycans/analysis Collagen/analysis Decorin Endothelial Growth Factors/analysis Endothelium, Vascular/chemistry Epithelial Cells/chemistry Extracellular Matrix Proteins Female Fibrocystic Breast Disease/metabolism,pathology Fibronectins/analysis Frozen Sections Humans In Situ Hybridization Lectins, C-Type Lymphatic Metastasis Lymphokines/analysis Neoplasm Invasiveness Neoplasm Metastasis Neoplasm Proteins/analysis Neovascularization, Pathologic Protein Isoforms/analysis Proteoglycans/analysis Proto-Oncogene Proteins/analysis RNA, Messenger/analysis RNA, Neoplasm/analysis Receptor Protein-Tyrosine Kinases/analysis Receptors, Growth Factor/analysis Receptors, Vascular Endothelial Growth Factor Stromal Cells/pathology Thrombospondin 1/analysis Vascular Endothelial Growth Factor A Vascular Endothelial Growth Factor Receptor-1 Vascular Endothelial Growth Factors Versicans
Chemicals
Biomarkers Chondroitin Sulfate Proteoglycans DCN protein, human Decorin Endothelial Growth Factors Extracellular Matrix Proteins Fibronectins Lectins, C-Type Lymphokines Neoplasm Proteins Protein Isoforms Proteoglycans Proto-Oncogene Proteins RNA, Messenger RNA, Neoplasm Receptors, Growth Factor Thrombospondin 1 VCAN protein, human Vascular Endothelial Growth Factor A Vascular Endothelial Growth Factors Versicans Collagen Receptor Protein-Tyrosine Kinases Receptors, Vascular Endothelial Growth Factor Vascular Endothelial Growth Factor Receptor-1
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Brown L F
Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215, USA.
Guidi A J
Schnitt S J
Van De Water L
Iruela-Arispe M L
Yeo T K
Tognazzi K
Dvorak H F
Article Info
Journal
Clinical cancer research : an official journal of the American Association for Cancer Research
Abbr.
Clin Cancer Res
ISSN
1078-0432
Published
1999-05-00
Pages
1041-56
Language
English
Region
United States
NLM ID
9502500
Subset
IM
Grants
NCI NIH HHS · CA50453 · United States
NCI NIH HHS · CA58845 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com